A detailed history of Richardson Financial Services Inc. transactions in Genmab A/S stock. As of the latest transaction made, Richardson Financial Services Inc. holds 42 shares of GMAB stock, worth $864. This represents 0.0% of its overall portfolio holdings.

Number of Shares
42
Previous 21 100.0%
Holding current value
$864
Previous $528,000 96.97%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$23.84 - $28.48 $500 - $598
21 Added 100.0%
42 $1.04 Million
Q1 2024

May 03, 2024

BUY
$26.43 - $32.77 $555 - $688
21 New
21 $628,000

Others Institutions Holding GMAB

About GENMAB A/S


  • Ticker GMAB
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 658,292,992
  • Market Cap $13.6B
  • Description
  • Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...
More about GMAB
Track This Portfolio

Track Richardson Financial Services Inc. Portfolio

Follow Richardson Financial Services Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Richardson Financial Services Inc., based on Form 13F filings with the SEC.

News

Stay updated on Richardson Financial Services Inc. with notifications on news.